Chapter 23. Recent Advances in the Discovery and Development of Potential Antidiabetic Agents.

This publication has 51 references indexed in Scilit:

• Pathogenesis of NIDDM: A Balanced Overview
  Diabetes Care, 1992
• Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression
  Endocrinology, 1992
• Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow mice
  Life Sciences, 1991
• Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agents
  Biochemical and Biophysical Research Communications, 1991
• Insulin action 1991
  Clinical Endocrinology, 1991
• Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Discrepancies in Lipolytic Activities Induced by β-Adrenoceptor Agonists in Human and Rat Adipocytes
  Hormone and Metabolic Research, 1990
• Sensitivity of fructose-1,6-biphosphatase from yeast, liver and skeletal muscle to fructose-2,6-biphosphate and 5?-adenosine monophosphate
  Zeitschrift für Lebensmittel-Untersuchung und Forschung, 1988
• Effect of the α2-blocker DG-5128 on insulin and somatostatin release from the isolated perfused rat pancreas
  Life Sciences, 1987
• Effect of a novel thermogenic β-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats
  Biochemical and Biophysical Research Communications, 1985